These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23242615)

  • 1. Trastuzumab administration during pregnancy: a systematic review and meta-analysis.
    Zagouri F; Sergentanis TN; Chrysikos D; Papadimitriou CA; Dimopoulos MA; Bartsch R
    Breast Cancer Res Treat; 2013 Jan; 137(2):349-57. PubMed ID: 23242615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab administration during pregnancy: an update.
    Andrikopoulou A; Apostolidou K; Chatzinikolaou S; Bletsa G; Zografos E; Dimopoulos MA; Zagouri F
    BMC Cancer; 2021 Apr; 21(1):463. PubMed ID: 33902516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
    Cardonick E; Usmani A; Ghaffar S
    Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trastuzumab treatment for breast cancer during pregnancy.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Can Fam Physician; 2008 Jan; 54(1):31-2. PubMed ID: 18208949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
    Azim HA; Metzger-Filho O; de Azambuja E; Loibl S; Focant F; Gresko E; Arfi M; Piccart-Gebhart M
    Breast Cancer Res Treat; 2012 May; 133(1):387-91. PubMed ID: 22367645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.
    Xia LY; Hu QL; Zhou Q
    BMC Womens Health; 2021 Apr; 21(1):169. PubMed ID: 33882925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab use for metastatic breast cancer in pregnancy.
    Sekar R; Stone PR
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes for breast cancer during pregnancy: a systematic review.
    Zagouri F; Sergentanis TN; Chrysikos D; Dimitrakakis C; Tsigginou A; Zografos CG; Dimopoulos MA; Papadimitriou CA
    Clin Breast Cancer; 2013 Feb; 13(1):16-23. PubMed ID: 23122538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological malignancies and pregnancy: treat or no treat during first trimester.
    Avilés A; Neri N; Nambo MJ
    Int J Cancer; 2012 Dec; 131(11):2678-83. PubMed ID: 22511239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
    Beale JM; Tuohy J; McDowell SJ
    Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
    Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
    Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case Report on Treatment of Metastatic Breast Cancer with Trastuzumab during Pregnancy].
    Rasenack R; Gaupp N; Rautenberg B; Stickeler E; Prömpeler H
    Z Geburtshilfe Neonatol; 2016 Apr; 220(2):81-3. PubMed ID: 27111595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
    Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
    Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes for ovarian cancer during pregnancy: a systematic review.
    Zagouri F; Sergentanis TN; Chrysikos D; Filipits M; Bartsch R
    Oncology; 2012; 83(4):234-8. PubMed ID: 22907101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children exposed to chemotherapy in utero.
    Gwyn K
    J Natl Cancer Inst Monogr; 2005; (34):69-71. PubMed ID: 15784828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal outcome after in utero exposure to cancer chemotherapy.
    Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
    Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.
    ; Ustaalioglu BB; Gumus M; Unal A; Cayir K; Sever O; Bilici A; Elkiran ET; Karaca H; Benekli M; Karaoglu A; Seker M
    Int J Gynecol Cancer; 2010 Jul; 20(5):698-703. PubMed ID: 20973261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.
    Amant F; Van Calsteren K; Halaska MJ; Gziri MM; Hui W; Lagae L; Willemsen MA; Kapusta L; Van Calster B; Wouters H; Heyns L; Han SN; Tomek V; Mertens L; Ottevanger PB
    Lancet Oncol; 2012 Mar; 13(3):256-64. PubMed ID: 22326925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.